{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:50:40Z","timestamp":1789602640160,"version":"build-2803163510"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union's Horizon 2020 research and innovation program"},{"name":"Marie Sklodowska-Curie","award":["642738"],"award-info":[{"award-number":["642738"]}]},{"name":"MetaRNA"},{"name":"European Union's Horizon 2020","award":["ERC-2014-StG"],"award-info":[{"award-number":["ERC-2014-StG"]}]},{"name":"European Union's Horizon 2020","award":["638902"],"award-info":[{"award-number":["638902"]}]},{"name":"LimitMDR"},{"DOI":"10.13039\/501100004836","name":"Danish Council for Independent Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sapere Aude Program DFF","award":["4004-00213"],"award-info":[{"award-number":["4004-00213"]}]},{"name":"The Novo Nordisk Foundation","award":["NNF10CC1016517"],"award-info":[{"award-number":["NNF10CC1016517"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Antibiotic combinations are considered a relevant strategy to tackle the global antibiotic resistance crisis since they are believed to increase treatment efficacy and reduce resistance evolution (WHO treatment guidelines for drug-resistant tuberculosis: 2016 update.). However, studies of the evolution of bacterial resistance to combination therapy have focused on a limited number of drugs and have provided contradictory results (Lipsitch, Levin BR. 1997; Hegreness et al. 2008; Munck et al. 2014). To address this gap in our understanding, we performed a large-scale laboratory evolution experiment, adapting eight replicate lineages of Escherichia coli to a diverse set of 22 different antibiotics and 33 antibiotic pairs. We found that combination therapy significantly limits the evolution of de novode novo resistance in E.\u00a0coli, yet different drug combinations vary substantially in their propensity to select for resistance. In contrast to current theories, the phenotypic features of drug pairs are weak predictors of resistance evolution. Instead, the resistance evolution is driven by the relationship between the evolutionary trajectories that lead to resistance to a drug combination and those that lead to resistance to the component drugs. Drug combinations requiring a novel genetic response from target bacteria compared with the individual component drugs significantly reduce resistance evolution. These data support combination therapy as a treatment option to decelerate resistance evolution and provide a novel framework for selecting optimized drug combinations based on bacterial evolutionary responses.<\/jats:p>","DOI":"10.1093\/molbev\/msab006","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T02:50:09Z","timestamp":1610506209000},"page":"2057-2069","source":"Crossref","is-referenced-by-count":35,"title":["Compatibility of Evolutionary Responses to Constituent Antibiotics Drive Resistance Evolution to Drug Pairs"],"prefix":"10.1093","volume":"38","author":[{"given":"Leonie Johanna","family":"Jahn","sequence":"first","affiliation":[{"name":"Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Simon","sequence":"additional","affiliation":[{"name":"Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Jensen","sequence":"additional","affiliation":[{"name":"Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Bradshaw","sequence":"additional","affiliation":[{"name":"Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Mostafa Hashim","family":"Ellabaan","sequence":"additional","affiliation":[{"name":"Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Otto Alexander","family":"Sommer","sequence":"additional","affiliation":[{"name":"Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"2021050507190622800_msab006-B2","author":"Bache","year":"2014"},{"issue":"2","key":"2021050507190622800_msab006-B3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/AAC.48.2.392-395.2004","article-title":"Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance","volume":"48","author":"Bantar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2021050507190622800_msab006-B6166269","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/JB.182.12.3467-3474.2000","article-title":"Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA","volume":"182","author":"Barbosa","year":"2000","journal-title":"J Bacteriol"},{"issue":"6","key":"2021050507190622800_msab006-B4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/molbev\/msv033","article-title":"The effect of selection environment on the probability of parallel evolution","volume":"32","author":"Bailey","year":"2015","journal-title":"Mol Biol Evol"},{"issue":"4","key":"2021050507190622800_msab006-B5","doi-asserted-by":"crossref","first-page":"e2004356","DOI":"10.1371\/journal.pbio.2004356","article-title":"Antibiotic combination efficacy (ACE) networks for a Pseudomonas aeruginosa model","volume":"16","author":"Barbosa","year":"2018","journal-title":"PLoS Biol"},{"issue":"9","key":"2021050507190622800_msab006-B6","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1093\/molbev\/msx158","article-title":"Alternative evolutionary paths to bacterial antibiotic resistance cause distinct collateral effects","volume":"34","author":"Barbosa","year":"2017","journal-title":"Mol Biol Evol"},{"issue":"6268","key":"2021050507190622800_msab006-B7","doi-asserted-by":"crossref","first-page":"aad3292","DOI":"10.1126\/science.aad3292","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","volume":"351","author":"Baym","year":"2016","journal-title":"Science"},{"key":"2021050507190622800_msab006-B8","first-page":"712","article-title":"Collateral susceptibility of isoniazid-resistant tubercle bacilli to nitrofurans","volume":"88","author":"Beutner","year":"1963","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"2021050507190622800_msab006-B9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/430912","article-title":"Effect of aminoglycoside and \u03b2-lactam combination therapy versus \u03b2-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials","volume":"41","author":"Bliziotis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021050507190622800_msab006-B10","first-page":"61","article-title":"The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis","volume":"79","author":"Blomberg","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2021050507190622800_msab006-B11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jinf.2018.05.009","article-title":"Community-acquired meningitis in adults caused by Escherichia coli in Denmark and The Netherlands","volume":"77","author":"Bodilsen","year":"2018","journal-title":"J Infect"},{"issue":"3","key":"2021050507190622800_msab006-B12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/11.3.361","article-title":"Inoculum effect","volume":"11","author":"Brook","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"5","key":"2021050507190622800_msab006-B13","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/1365-2745.12969","article-title":"The environmental triangle of the Cerrado Domain: ecological factors driving shifts in tree species composition between forests and savannas","volume":"106","author":"Bueno","year":"2018","journal-title":"J Ecol"},{"key":"2021050507190622800_msab006-B14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.15252\/msb.20156098","article-title":"Systematic discovery of drug interaction mechanisms","volume":"11","author":"Chevereau","year":"2015","journal-title":"Mol Syst Biol"},{"issue":"5","key":"2021050507190622800_msab006-B8678200","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1128\/JB.175.5.1484-1492.1993","article-title":"Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli","volume":"175","author":"Cohen","year":"1993","journal-title":"J Bacteriol"},{"issue":"5","key":"2021050507190622800_msab006-B15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/molbev\/msv006","article-title":"Collateral resistance and sensitivity modulate evolution of high-level resistance to drug combination treatment in Staphylococcus aureus","volume":"32","author":"de Evgrafov","year":"2015","journal-title":"Mol Biol Evol"},{"key":"2021050507190622800_msab006-B16","author":"Dowle","year":"2018"},{"issue":"11","key":"2021050507190622800_msab006-B17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nchembio.1911","article-title":"Synergistic, collaterally sensitive \u03b2-lactam combinations suppress resistance in MRSA","volume":"11","author":"Gonzales","year":"2015","journal-title":"Nat Chem Biol"},{"key":"2021050507190622800_msab006-B18","author":"Grosjean","year":"2018"},{"issue":"37","key":"2021050507190622800_msab006-B19","doi-asserted-by":"crossref","first-page":"13977","DOI":"10.1073\/pnas.0805965105","article-title":"Accelerated evolution of resistance in multidrug environments","volume":"105","author":"Hegreness","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"2021050507190622800_msab006-B20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2017.12.012","article-title":"Drug-Driven phenotypic convergence supports rational treatment strategies of chronic infections","volume":"172","author":"Imamovic","year":"2018","journal-title":"Cell"},{"issue":"204","key":"2021050507190622800_msab006-B21","doi-asserted-by":"crossref","first-page":"204ra132","DOI":"10.1126\/scitranslmed.3006609","article-title":"Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development","volume":"5","author":"Imamovic","year":"2013","journal-title":"Sci Transl Med"},{"key":"2021050507190622800_msab006-B22","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00816","article-title":"Adaptive laboratory evolution of antibiotic resistance using different selection regimes lead to similar phenotypes and genotypes","volume":"8","author":"Jahn","year":"2017","journal-title":"Front Microbiol"},{"issue":"1","key":"2021050507190622800_msab006-B23","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1038\/s41598-018-25201-5","article-title":"Chromosomal barcoding as a tool for multiplexed phenotypic characterization of laboratory evolved lineages","volume":"8","author":"Jahn","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"2021050507190622800_msab006-B24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.drup.2014.02.002","article-title":"Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance","volume":"16","author":"Jansen","year":"2013","journal-title":"Drug Resist Update"},{"issue":"5","key":"2021050507190622800_msab006-B25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1099\/jmm.0.024083-0","article-title":"Bacterial hypermutation: clinical implications","volume":"60","author":"Jolivet-Gougeon","year":"2011","journal-title":"J Med Microbiol"},{"key":"2021050507190622800_msab006-B26","author":"Kassambara","year":"2018"},{"issue":"1","key":"2021050507190622800_msab006-B96","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jac\/dkm397","article-title":"MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli","volume":"61","author":"Keeney","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2021050507190622800_msab006-B27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/gbe\/evu106","article-title":"Genomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplification","volume":"6","author":"Laehnemann","year":"2014","journal-title":"Genome Biol Evol"},{"issue":"1","key":"2021050507190622800_msab006-B28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/msb.2013.57","article-title":"Bacterial evolution of antibiotic hypersensitivity","volume":"9","author":"L\u00e1z\u00e1r","year":"2013","journal-title":"Mol Syst Biol"},{"issue":"7311","key":"2021050507190622800_msab006-B29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature09354","article-title":"Bacterial charity work leads to population-wide resistance","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"issue":"5","key":"2021050507190622800_msab006-B30","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.41.5.1127","article-title":"Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study","volume":"41","author":"Leibovici","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"6327","key":"2021050507190622800_msab006-B31","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.aaj2191","article-title":"Antibiotic tolerance facilitates the evolution of resistance","volume":"355","author":"Levin-Reisman","year":"2017","journal-title":"Science"},{"issue":"13","key":"2021050507190622800_msab006-B32","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/bioinformatics\/btl158","article-title":"Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences","volume":"22","author":"Li","year":"2006","journal-title":"Bioinformatics"},{"issue":"3","key":"2021050507190622800_msab006-B33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/cid\/cix780","article-title":"Should the aminoglycoside \u03b2-lactam combination be abandoned in all severely ill patients with presumed gram-negative infection?","volume":"66","author":"Lipcsey","year":"2018","journal-title":"Clin Infect Dis Oxf Acad"},{"issue":"2","key":"2021050507190622800_msab006-B34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/AAC.41.2.363","article-title":"The population dynamics of antimicrobial chemotherapy","volume":"41","author":"Lipsitch","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2021050507190622800_msab006-B35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/phar.1868","article-title":"Past, present, and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline, and societal implications","volume":"37","author":"Luepke","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"2","key":"2021050507190622800_msab006-B36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/jeb.13006","article-title":"The probability of parallel genetic evolution from standing genetic variation","volume":"30","author":"MacPherson","year":"2017","journal-title":"J Evol Biol"},{"key":"2021050507190622800_msab006-B37","first-page":"28:1","author":"Mauri","year":"2017"},{"key":"2021050507190622800_msab006-B38","author":"McKenzie","year":"2016"},{"issue":"2","key":"2021050507190622800_msab006-B39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.00999-09","article-title":"Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro\u2013in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus","volume":"54","author":"Meletiadis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2021050507190622800_msab006-B40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41467-018-03447-x","article-title":"Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole","volume":"9","author":"Minato","year":"2018","journal-title":"Nat Commun"},{"issue":"262","key":"2021050507190622800_msab006-B41","doi-asserted-by":"crossref","first-page":"262ra156","DOI":"10.1126\/scitranslmed.3009940","article-title":"Prediction of resistance development against drug combinations by collateral responses to component drugs","volume":"6","author":"Munck","year":"2014","journal-title":"Sci Transl Med"},{"key":"2021050507190622800_msab006-B42","author":"Oksanen","year":"2019"},{"issue":"1","key":"2021050507190622800_msab006-B43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/JB.178.1.306-308.1996","article-title":"AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants","volume":"178","author":"Okusu","year":"1996","journal-title":"J Bacteriol"},{"key":"2021050507190622800_msab006-B44","article-title":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","volume-title":"Cochrane Database Syst Rev","author":"Paul","year":"2014"},{"issue":"12","key":"2021050507190622800_msab006-B45","doi-asserted-by":"crossref","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose\u2013response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"2021050507190622800_msab006-B46","doi-asserted-by":"crossref","first-page":"e1001540","DOI":"10.1371\/journal.pbio.1001540","article-title":"When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition","volume":"11","author":"Pena-Miller","year":"2013","journal-title":"PLoS Biol"},{"issue":"13","key":"2021050507190622800_msab006-B9388491","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1128\/JB.183.13.3890-3902.2001","article-title":"Genome-wide transcriptional profiling of the Escherichia coli responses to superoxide stress and sodium salicylate","volume":"183","author":"Pomposiello","year":"2001","journal-title":"J Bacteriol"},{"issue":"2","key":"2021050507190622800_msab006-B47","doi-asserted-by":"crossref","first-page":"e90441","DOI":"10.1371\/journal.pone.0090441","article-title":"Beneficial antimicrobial effect of the addition of an aminoglycoside to a \u03b2-lactam antibiotic in an E.\u00a0coli porcine intensive care severe sepsis model","volume":"9","author":"Skorup","year":"2014","journal-title":"PLoS One"},{"key":"2021050507190622800_msab006-B48","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat Microbiol"},{"issue":"4","key":"2021050507190622800_msab006-B49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jbiosc.2015.02.003","article-title":"Suppression of antibiotic resistance acquisition by combined use of antibiotics","volume":"120","author":"Suzuki","year":"2015","journal-title":"J Biosci Bioeng"},{"issue":"4","key":"2021050507190622800_msab006-B50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/JB.64.4.489-499.1952","article-title":"Genetic studies on microbial cross resistance to toxic agents I. Cross resistance of Escherichia coli to fifteen antibiotics1, 2","volume":"64","author":"Szybalski","year":"1952","journal-title":"J Bacteriol"},{"issue":"9","key":"2021050507190622800_msab006-B51","doi-asserted-by":"crossref","first-page":"e1005745","DOI":"10.1371\/journal.pcbi.1005745","article-title":"Modeling antibiotic treatment in hospitals: a systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies","volume":"13","author":"Tepekule","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"2021050507190622800_msab006-B52","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/80bc1e50-d623-464f-817f-a5e776b75717","article-title":"Optimal drug synergy in antimicrobial treatments","volume":"6","author":"Torella","year":"2010","journal-title":"PLoS Comput. Biol"},{"issue":"3","key":"2021050507190622800_msab006-B53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"2021050507190622800_msab006-B54","first-page":"277","article-title":"The antibiotic resistance crisis","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm Ther"},{"issue":"2","key":"2021050507190622800_msab006-B55","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/genetics\/162.2.961","article-title":"Evaluating the impact of population bottlenecks in experimental evolution","volume":"162","author":"Wahl","year":"2002","journal-title":"Genetics"},{"key":"2021050507190622800_msab006-B56","author":"Warnes","year":"2017"},{"issue":"1","key":"2021050507190622800_msab006-B57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i01","article-title":"The split-apply-combine strategy for data analysis","volume":"40","author":"Wickham","year":"2011","journal-title":"J Stat Soft"},{"key":"2021050507190622800_msab006-B58","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"2021050507190622800_msab006-B59","author":"Wickham","year":"2018"},{"key":"2021050507190622800_msab006-B60","author":"Wickham","year":"2018"},{"key":"2021050507190622800_msab006-B61","author":"Wickham","year":"2018"},{"key":"2021050507190622800_msab006-B62","author":"Wickham","year":"2018"},{"key":"2021050507190622800_msab006-B63","author":"Wilke","year":"2018"},{"key":"2021050507190622800_msab006-B64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fmicb.2017.00246","article-title":"Epistasis and the evolution of antimicrobial resistance","volume":"8","author":"Wong","year":"2017","journal-title":"Front Microbiol"},{"issue":"1","key":"2021050507190622800_msab006-B65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-0691.2006.01492.x","article-title":"The emergence of antibiotic resistance by mutation","volume":"13","author":"Woodford","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"2021050507190622800_msab006-B66","year":"2016"},{"issue":"19","key":"2021050507190622800_msab006-B67","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/JB.185.19.5657-5664.2003","article-title":"AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity","volume":"185","author":"Yu","year":"2003","journal-title":"J Bacteriol"}],"container-title":["Molecular Biology and Evolution"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mbe\/advance-article-pdf\/doi\/10.1093\/molbev\/msab006\/36428453\/msab006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mbe\/article-pdf\/38\/5\/2057\/37799127\/msab006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mbe\/article-pdf\/38\/5\/2057\/37799127\/msab006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T13:55:17Z","timestamp":1620222917000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mbe\/article\/38\/5\/2057\/6108108"}},"subtitle":[],"editor":[{"given":"Tal","family":"Pupko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,2,22]]},"published-print":{"date-parts":[[2021,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/molbev\/msab006","relation":{},"ISSN":["1537-1719"],"issn-type":[{"value":"1537-1719","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2021,2,22]]}}}